Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Opioid Induced Constipation | Treatment Algorithms: Claims Data Analysis | US | 2021
The drug market for opioid induced constipation (OIC) is served by a variety of prescription medications, including several agents that are approved for irritable bowel syndrome with constipation (…
Systemic Lupus Erythematosus | Treatment Algorithms | Claims Data Analysis | US ALGOIM0041-2021
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. SLE symptoms range from general malaise to serious central nervous system and renal…
Irritable Bowel Syndrome | Treatment Algorithms: Claims Data Analysis | IBS Without Diarrhea (Including IBS-Constipation) | US | 2021
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is generally classified into three…
Asthma | Treatment Algorithms: Claims Data Analysis | Pediatric Asthma | US | 2021
Pediatric asthma is treated using two types of pharmacotherapies: rescue therapy for acute symptoms via bronchodilation (e.g., a SABA such as ProAir HFA or its generics) and maintenance therapy to…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Spontaneous | US | 2021
The drug market for chronic spontaneous urticaria (CSU), previously know as chronic idiopathic urticaria, is dominated by oral medications, including first- and second-generation (nondrowsy)…
